Joe Biden Diagnosed with Advanced Prostate Cancer and Bone Metastasis: What You Need to Know

Joe Biden, at age 82, has been diagnosed with an aggressive prostate cancer that has spread to his bones. Learn about prostate cancer stages, treatment options, and the importance of early detection.
Former U.S. President Joe Biden, aged 82, has been diagnosed with an aggressive form of prostate cancer that has already spread to his bones, indicating an advanced stage of the disease. The diagnosis was made after Biden sought medical attention for worsening urinary symptoms—a common sign that prompts further investigation. A small nodule on his prostate led to detailed testing, revealing a high-grade tumor with a Gleason score of nine out of ten, which signifies a highly aggressive and rapidly growing cancer.
Prostate cancer remains the second most frequently diagnosed cancer in men worldwide, especially affecting those over 50. The prostate is a walnut-sized gland involved in seminal fluid production, located beneath the bladder. While many prostate cancers progress slowly and may not cause significant health issues, some, like Biden’s, are swift and capable of spreading quickly before noticeable symptoms emerge.
The Gleason scoring system, used to grade prostate tumors, ranges from six to ten, with higher scores indicating more aggressive cancers. A score of nine suggests the cancer cells are highly abnormal and likely to metastasize rapidly. Since Biden’s cancer has already metastasized to his bones, he is classified as stage four, the most advanced stage with limited curability but potential for management.
Biden’s case features hormone-sensitive prostate cancer, meaning the cancer cells depend on male hormones like testosterone for growth. Treatments often involve hormone therapy to block or reduce hormone levels, which can be effective initially. These therapies may be combined with chemotherapy, targeted medications, and drugs to prevent or reduce bone-related complications such as fractures and severe pain.
Early-stage prostate cancer typically presents no symptoms, underscoring the importance of regular screening, especially for men over 50 or those with a family history. When symptoms occur, they may include frequent urination, difficulty starting or stopping urination, or a sensation of bladder fullness. Advanced cancer may cause pain in the hips, back, or pelvis, as well as fatigue or unexplained weight loss, which contributed to Biden’s decision to seek medical care.
The public response to Biden’s diagnosis has been one of concern and bipartisan support, drawing attention to prostate cancer awareness. It highlights issues surrounding the importance of early detection, access to screening, and disparities in healthcare outcomes. The stark reality is that about one in eight men will be diagnosed with prostate cancer in their lifetime. For many, it remains non-life-threatening, but others face aggressive forms that develop quickly.
This diagnosis serves as a reminder that cancer can affect anyone regardless of stature or status. Listening to one’s body and seeking prompt medical advice is crucial. Advances in medical research have improved treatment options, allowing patients to maintain a good quality of life even with advanced disease. Biden’s experience may motivate more men to prioritize their health, get screened regularly, and consult healthcare professionals proactively.
With appropriate treatment, even stage four prostate cancer can be managed to some extent. The focus is on controlling disease progression, alleviating symptoms, and improving quality of life. Biden’s journey underscores the importance of early detection, personalized therapy, and ongoing medical advancements, offering hope to millions affected by this disease.
Source: https://medicalxpress.com/news/2025-05-joe-biden-prostate-cancer-bone.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Missouri Legislation Boosts Breast Cancer Screening Rates
Legislative changes in Missouri have led to increased breast cancer screening rates, especially among Medicaid patients, with greater adoption of advanced imaging techniques like digital breast tomosynthesis. This policy shift contributes to early detection efforts and reducing disparities in breast cancer outcomes.
AI-Driven Eye Scans Predict Risk of Cognitive Decline and Dementia
Researchers from NUS Medicine have developed an AI-based retinal imaging biomarker, RetiPhenoAge, which predicts the risk of cognitive decline and dementia. This innovative, non-invasive tool aids early detection and could transform cognitive health screening worldwide.
Trending Rise in Women Freezing Eggs Despite Low Return Rates
A recent UCLA study shows a surge in women choosing to freeze their eggs, with low rates of subsequent usage, highlighting evolving reproductive behaviors and technological success in fertility preservation.
Harnessing Deep Learning for Personalized Cancer Treatment
Deep learning algorithms such as Flexynesis are revolutionizing personalized cancer treatment by integrating multi-omics data to improve diagnosis and therapy strategies. Learn how AI is shaping the future of oncology.



